Thymidylate synthase (TS), dihydrofolate reductase (DHFR), GARFT
Assets acting on this target.
- Class
- Multi-targeted antifolate chemotherapy (pemetrexed)
- Pathway
- Inhibits folate-dependent enzymes required for de novo thymidine and purine nucleotide biosynthesis, blocking DNA replication
Related mechanisms
Dihydrofolate reductase (DHFR) (1)Thymidylate synthase (via 5-FU, released from tegafur) and dihydropyrimidine dehydrogenase (inhibited by gimeracil) (1)Aldosterone synthase (CYP11B2) (7)Fatty acid synthase (FASN) (4)HMG-CoA reductase / NPC1L1 (4)Angiotensin II receptor / Calcium channel / HMG-CoA reductase (3)